论文部分内容阅读
目的:研究合理使用成分血,对上消化道出血患者治疗的效果及对患者的影响.方法:选取63例实施输血治疗的上消化道出血患者,在2019年3月至2021年3月期间于本院接受治疗,分为参考组(31例实施常规输血方案)和试验组(32例实施定制输血方案),对比两组患者各项临床指标.结果:输血后,试验组血小板检测相较于参考组更具显著性(P＜0.05);参考组患者的凝血酶原时间及活化部分凝血活酶时间相较于试验组更具显著性(P＜0.05).结论:对上消化道出血患者治疗时实施合理使用成分血,可最大程度上降低患者的痛苦,提高血小“,”Objective:To study the rational use of blood components, the effect of the treatment of patients with upper gastrointestinal bleeding and the impact on the patients. Methods:Sixty-three patients with upper gastrointestinal hemorrhage who underwent blood transfusion were selected and received treatment in this hospital from March 2019 to March 2021. They were divided into a reference group (31 patients underwent routine blood transfusion) and a test group (32 patients underwent treatment) Customized blood transfusion program), compare the clinical indicators of the two groups of patients. Results:After blood transfusion, the detection of platelets in the test group was more significant than that of the reference group (P＜0.05); the prothrombin time and activated partial thromboplastin time of patients in the reference group were more significant than those in the test group (P＜0.05). 0.05). Conclusion:The rational use of blood components in the treatment of patients with upper gastrointestinal bleeding can minimize the suffering of patients and increase the value of platelet detection. It is worthy of clinical promotion.